C12N 2501/335
Glucagon
Official title: Glucagon; Glucagon-like peptide [GLP]; Exendin
C12N2501/335 (Glucagon) appears on 113 US grants and 159 published applications in this corpus.
Search patents in C12N- Granted patents
- 113
- Published applications
- 159
- Assignees
- 84
- Inventors
- 234
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 8 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 2 |
| 2002 | 2 | 7 |
| 2003 | 2 | 8 |
| 2004 | 0 | 7 |
| 2005 | 4 | 8 |
| 2006 | 3 | 10 |
| 2007 | 5 | 10 |
| 2008 | 1 | 9 |
| 2009 | 5 | 5 |
| 2010 | 4 | 4 |
| 2011 | 3 | 4 |
| 2012 | 6 | 6 |
| 2013 | 4 | 7 |
| 2014 | 4 | 8 |
| 2015 | 5 | 8 |
| 2016 | 4 | 5 |
| 2017 | 7 | 6 |
| 2018 | 4 | 5 |
| 2019 | 3 | 5 |
| 2020 | 4 | 6 |
| 2021 | 1 | 7 |
| 2022 | 3 | 8 |
| 2023 | 5 | 3 |
| 2024 | 6 | 5 |
| 2025 | 0 | 2 |
| 2026 | 5 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for amplifying and differentiating pancreatic cells, and application thereof23 Jun 2026US 12,662,660 B2Shanghai Celliver Biotechnology Co., Ltd.
- Method of increasing proliferation of pancreatic beta cells, treatment method, and composition19 May 2026US 12,630,803 B2Icahn School of Medicine at Mount Sinai
- Composition comprising exosomes derived from induced pluripotent stem cell-derived mesenchymal stem cell progenitor for prevention or treatment of non-alcoholic steatohepatitis7 Apr 2026US 12,594,303 B2Brexogen Inc.
- Use of ENTPD3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells7 Apr 2026US 12,594,306 B2The Regents of the University of Colorado, a body corporate
- Functional feline pancreatic cells from adipose tissue24 Mar 2026US 12,584,110 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof8 Oct 2026US 2026/0308529 A1Imagine Pharma LLC
- Method for producing metabolically activated liver organoid, composition, and method for evaluating test substance2 Jul 2026US 2026/0185054 A1Jsr Corporation
- Pancreatic cells for treating diabetes and methods of generating the same14 May 2026US 2026/0130949 A1Seraxis, Inc.
- Pharmaceutical composition for treating wound repair and preparation method thereof12 Feb 2026US 2026/0041716 A1Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Composition for promoting production of stem cell-derived exosomes and increasing stemness27 Feb 2025US 2025/0066721 A1Brexogen Inc.
Most cited
By later US patents
- Three-dimensional cell and tissue culture system322US 4,963,489 AMarrow-Tech Incorporated · 1990
- Three-dimensional cartilage cultures289US 5,902,741 AAdvanced Tissue Sciences, Inc. · 1999
- Three-dimensional cell and tissue culture system258US 5,443,950 AAdvanced Tissue Sciences, Inc. · 1995
- Three-dimensional culture of pancreatic parenchymal cells cultured living stromal tissue prepared in vitro220US 6,022,743 AAdvanced Tissue Sciences, Inc. · 2000
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006